EdiGene

About:

EdiGene is a biotechnology company that develops genome editing technologies.

Website: http://edigene.com

Twitter/X: Edigene_Inc

Top Investors: HongShan, Lilly Asia Ventures, IDG Capital, Huagai Capital, WI Harper Group

Description:

EdiGene is dedicated to the development of genome editing technology for human health. Genome editing technology enables the targeted modification of genetic information in human cells, including gene knockout, knock-in and targeted mutations. They aim at providing the high quality products and services for the patients, the pharmaceutical industry, and the scientific research community with the most advanced genome editing technology.EdiGene innovates and applies genome editing technology to developing human therapeutic products. Their therapeutic approach is to treat diseases at the molecular level, making gene therapy safer and more effective.